Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection

被引：4

作者：

Larry M. Baddour

机构：

来源：

Current Infectious Disease Reports | 2002年 / 4卷 / 5期

关键词：

Adjunctive Therapy; Lenograstim; Amputation Rate; Prospective Control Trial; Peripheral Leukocyte Count;

D O I：

10.1007/s11908-002-0007-1

中图分类号：

学科分类号：

摘要：

引用

页码：413 / 414

页数：1

共 13 条

[1]

Souza LM(1986)Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells Science 232 61-65

[2]

Boone TC(1997)Randomized placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection Lancet 350 855-859

[3]

Gabrilove J(1993)Evidence of ex vivo and in vivo impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus Diabetes Res Clin Pract 19 183-188

[4]

Gough A(2001)Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection Diabetes Obes Metab 3 332-337

[5]

Clapperton M(undefined)undefined undefined undefined undefined-undefined

[6]

Rolando N(undefined)undefined undefined undefined undefined-undefined

[7]

Marphhoffer W(undefined)undefined undefined undefined undefined-undefined

[8]

Stein M(undefined)undefined undefined undefined undefined-undefined

[9]

Schleinkofer L(undefined)undefined undefined undefined undefined-undefined

[10]

Frederlin K(undefined)undefined undefined undefined undefined-undefined

← 1 2 →